Repeat radiation therapy to the breast using proton therapy following a recurrence of breast cancer
- Gender
- Women
- Age
- 18 years and older
- Trial type
- Interventional
- Line of therapy
- Relapsed / refractory
- Phase
- —
What is this trial about?
For breast cancer, breast-conserving surgery followed by radiation therapy to the entire breast is a proven standard of care; however, in some cases, a recurrence may occur in the breast that has already been treated with radiation. In this case, a complete removal of the breast (mastectomy) is the treatment of choice. The goal of the BREAST study is to investigate whether repeated, targeted partial breast irradiation with proton therapy following a repeat breast-conserving surgery is a safe and well-tolerated treatment option. Women aged 18 and older with recurrent or newly diagnosed breast cancer in the previously irradiated breast who have undergone a repeat breast-conserving surgery are eligible to participate in this study.
Trial flow
Requirements
Diagnosis: breast cancer
Age: 18 years and older
Line of therapy: Unabhängig von Therapielinie
Key inclusion criteria: women; recurrent or new tumour in the breast that has already been treated with radiotherapy; following a repeat breast-conserving operation; new tumour smaller than 3 cm; no lymph nodes affected; tumour-free margins at the time of surgery (R0 resection); last radiotherapy session at least twelve months ago
Allocation
Einarmige Studie
Treatment
Follow-up
Diagnosis: breast cancer
Age: 18 years and older
Line of therapy: Unabhängig von Therapielinie
Key inclusion criteria: women; recurrent or new tumour in the breast that has already been treated with radiotherapy; following a repeat breast-conserving operation; new tumour smaller than 3 cm; no lymph nodes affected; tumour-free margins at the time of surgery (R0 resection); last radiotherapy session at least twelve months ago
Einarmige Studie
Detailed description
Breast cancer is the most common cancer among women. After breast-conserving surgery, the entire breast is typically treated with radiation to reduce the risk of recurrence. Nevertheless, some patients may experience a recurrence of the tumor in the same breast. Until now, a mastectomy (complete removal of the breast) has often been recommended in such cases, as repeat radiation therapy using conventional methods carries an increased risk of side effects on the skin and surrounding tissue that have already been irradiated. Proton therapy is a novel radiation treatment method with unique physical properties. The protons (positively charged particles) deliver their energy specifically to the tumor area (known as the Bragg peak), thereby better sparing the surrounding healthy tissue than conventional radiation therapy using photons. Proton therapy is already used as a radiation treatment for various types of cancer; however, in Germany, it has not yet been established as a treatment for repeat partial breast irradiation in cases of breast cancer recurrence.
The aim of this study is to investigate the efficacy and tolerability of partial breast irradiation with proton therapy following a repeat breast-conserving surgery. The treatment consists of 15 individual sessions. This is a single-arm study, meaning all patients receive the same treatment. The primary endpoint of the study is the occurrence of severe skin reactions (grade 3 or higher) within the first six months after the start of partial breast irradiation.
Women aged 18 and older with recurrent or newly diagnosed breast cancer in a breast that has already been treated with radiation, who have undergone a repeat breast-conserving surgery, are eligible to participate in this study. Additional eligibility criteria include, among others, that the recurrent tumor is smaller than 3 cm, no lymph nodes are involved, the tumor margins were tumor-free at the time of surgery (R0 resection), and at least twelve months have passed since the last radiation treatment.
Facts
- Disease: Breast cancer (mammary carcinoma)
- Cancer characteristics: Recurrent (reappeared) or newly developed in a breast that has already undergone radiation therapy, following repeat breast-conserving surgery
- What the study investigates: The efficacy and tolerability of repeat partial breast irradiation with proton therapy following a repeat breast-conserving surgery
- Study objective: To determine whether proton therapy can be used as an alternative treatment following a repeat breast-conserving surgery and to assess the frequency of severe skin reactions
- Study duration: up to approximately 6 months + up to 5 years of follow-up
- Study characteristics: single-arm, open-label
Trial sites
2 trial sites in Germany are listed.
Nationales Centrum für Tumorerkrankungen Heidelberg
Im Neuenheimer Feld 280, 69120 Heidelberg
RecruitingUniversity Hospital Heidelberg, Department Radiation Oncology
69120 Heidelberg
Recruiting
This list is compiled to the best of our knowledge but without guarantee: it may be incomplete, and a site's recruitment status can change at any time.
- Dr. med. Sebastian SommerSpecialist in internal medicine with a focus on hematology and oncology
- PD Dr. med. Matthias FröhlichSpecialist in internal medicine, immunology and emergency medicine
This description is based on the public trial registry (NCT06954623) and was translated into plain language by our medical editorial team. Whether participation is an option for you is a decision you make together with your treating physician.


